Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Recent News Surrounding Pain Medication Has Some Consumers Nervous About Safety
  • USA - English


News provided by

Chandler Chicco Agency

Dec 19, 2013, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Traumeel® 100 g Ointment
Traumeel® 100 g Ointment

Albuquerque, NM (PRWEB) December 19, 2013 -- As the American population ages, pain has become more prevalent. Pain affects more than 30 percent of people in the U.S.(1), which is more than heart disease, diabetes and cancer combined. The most common types of pain amongst Americans include lower back, joint and muscle pain.(2) Recent news surrounding pain medication has some consumers nervous about safety.

“Many physicians recommend traditional NSAIDs for musculoskeletal pain without taking into account the serious side effects,” said Dr. Steven Sampson. “I recommend Traumeel® to my patients who struggle with minor back, joint and muscle pain.”

Post this

Safety Concerns for Pain Products
A recent study published in The Lancet, shows high dose non-steroidal anti-inflammatory drugs (NSAIDs) may double the risk of heart attacks and heart failure, and NSAIDs may also cause damage to the liver and kidneys, and raise the risk of high blood pressure in certain populations.(3) Also, a recent report on the dangers of acetaminophen showed that approximately 150 Americans die each year from acetaminophen poisoning(4), and that as many as 78,000 Americans are sent to the emergency room annually due to acetaminophen overdose.(5) What’s concerning is that many people don’t even consider the risks of over-the-counter (OTC) medicines. According to a Pharmacy Times survey, 43% of the consumers who take OTC analgesics are not aware of the potential adverse events.(6)

But it’s not just OTC products that cause concern. Prescription drugs can have dangerous side effects as well. In fact, more than 200,000 emergency department visits for opioid misuse or abuse were reported among women between 2004 and 2010.(7) Shockingly, drug poisoning has superseded motor vehicle accidents as the leading cause of injury death in the country.(8) These deaths are mainly in the form of overdoses from prescription drugs.(9)

Alternative Options for Pain Relief
Due to the risk associated with pain relief products, complementary and alternative medicines (CAM) are becoming more popular. According to the Mayo Clinic, nearly 40 percent of adults report using CAM, and physicians too are embracing CAM therapy – often combining it with traditional therapy.(10)

“Many physicians recommend traditional non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain without taking into account the serious side effects, such as gastrointestinal bleeding and increased cardiovascular disease risks,” said Steven Sampson, DO, of the Orthohealing Center in Los Angeles, CA. “But safer and effective options do exist. For example, I recommend Traumeel® to my patients who struggle with minor back, joint and muscle pain.”

Traumeel®: Tough on Your Pain, Gentle on Your System
Traumeel® provides pain relief through a combination of 12 natural active ingredients (out of 14 actives). Traumeel® is easy to use and offers natural relief that works with your body to temporarily reduce minor joint, back and muscle pain. For flexibility of use and to maximize convenience, Traumeel® is available in multiple dosage forms including Traumeel® 50 g Ointment, Traumeel® 100 g Ointment, Traumeel® 50 g Gel, Traumeel® 250 g Gel, Traumeel® Oral Drops 50 ml, Traumeel® 100 ct Tablets and Traumeel® Combo Pack.

Traumeel®’s effectiveness was recently verified in a clinical study (TAASS) in Spain. Additionally, Traumeel® has not been associated with the type of side effects linked with NSAID use, like increased risk of ulcers and stomach bleeding, and is safe to use for more than 10 days. Traumeel® has been used by millions of people for more than 60 years. For more information about Traumeel®, please visit http://www.traumeel.us.

About Heel Inc.
Heel is a homeopathic pharmaceutical company that develops, manufactures and distributes medicines. Heel medicines are available through healthcare providers and fine natural product stores throughout the United States. For more information on other Heel products and their use, please visit http://www.heelusa.com.

Note: These statements have not been reviewed by the Food and Drug Administration. They are supported by traditional homeopathic principles.

###
_______________________________________________
(1) The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010 Nov ;11(11):1230-9. doi: 10.1016/j.jpain.2010.07.002. Epub 2010 Aug 25.
(2) National Pain Survey, conducted for Ortho-McNeil Pharmaceutical, 1999.
(3) Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. The Lancet, 2013; DOI: 10.1016/S0140-6736(13)60900-9.
(4) Gerth J. & Miller T. C. (20 Sept, 2013). Use Only as Directed. ProPublica. Retrieved from http://www.propublica.org/article/tylenol-mcneil-fda-use-only-as-directed.
(5) Gerth J. & Miller T. C. (20 Sept, 2013). Use Only as Directed. ProPublica. Retrieved from http://www.propublica.org/article/tylenol-mcneil-fda-use-only-as-directed.
(6) Cham E, Hall L, Ernst AA, Weiss SJ. Awareness and use of over-the-counter pain medications: a survey of emergency department patients. South Med J. 2002;95(5):529-535. http://www.pharmacytimes.com/publications/otc/2013/OTCGuide-2013/Pain-Control-Using-Nonprescription-Analgesics#sthash.C61xn0qe.Tu2k2yzV.dpuf
(7) CDC Vital Signs (July 2013). Prescription Painkiller Overdoses: A growing epidemic, especially among women. CDC. Retrieved from http://www.pharmacytimes.com/news/Opioid-Overdose-and-Death-Rates-Skyrocket-in-Women
(8) Osterweil, Neil (12 Nov, 2013). Prescription Drug Deaths Rise With Opioid Sales. Medscape. Retrieved from http://www.medscape.com/viewarticle/814200
(9) Osterweil, Neil (12 Nov, 2013). Prescription Drug Deaths Rise With Opioid Sales. Medscape. Retrieved from http://www.medscape.com/viewarticle/814200
(10) Mayo Clinic (2011). Complementary and Alternative Medicine. Retrieved from http://www.mayoclinic.com/health/alternative-medicine/PN00001.

Laura Amarillas, Chandler Chicco Agency, +1 (702) 263-5254, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.